PWAR5
gene geneOn this page
Also known as PAR5PAR-5
Summary
PWAR5 (Prader Willi/Angelman region RNA 5, HGNC:30090) is a long non-coding RNA gene on chromosome 15q11.2.
Predicted to be involved in RNA processing. Predicted to be located in nucleolus.
Source: NCBI Gene 8123 — RefSeq curated summary.
At a glance
- Gene type: non-coding (TEC) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30090 |
| Approved symbol | PWAR5 |
| Name | Prader Willi/Angelman region RNA 5 |
| Location | 15q11.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | PAR5, PAR-5 |
| Ensembl gene | ENSG00000279192 |
| Ensembl biotype | TEC |
| OMIM | 600162 |
| Entrez | 8123 |
| RNAcentral | URS000075990E — lncRNA, 3373 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 TEC
ENST00000624480
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000624480 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003759998 | 24985053 | 24988232 |
Expression profiles
Bgee: expression breadth ubiquitous, 116 present calls, max score 93.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5713 / max 379.9191, expressed in 121 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 145507 | 0.3468 | 74 |
| 145508 | 0.2245 | 72 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.19 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.89 | gold quality |
| uterine cervix | UBERON:0000002 | 79.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.06 | gold quality |
| corpus callosum | UBERON:0002336 | 78.22 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.72 | gold quality |
| calcaneal tendon | UBERON:0003701 | 76.34 | gold quality |
| sural nerve | UBERON:0015488 | 71.09 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 70.06 | gold quality |
| bone marrow cell | CL:0002092 | 69.82 | gold quality |
| tonsil | UBERON:0002372 | 68.44 | gold quality |
| cortical plate | UBERON:0005343 | 67.65 | gold quality |
| primary visual cortex | UBERON:0002436 | 67.59 | gold quality |
| bone marrow | UBERON:0002371 | 65.72 | gold quality |
| kidney | UBERON:0002113 | 65.45 | gold quality |
| stromal cell of endometrium | CL:0002255 | 64.32 | gold quality |
| ventricular zone | UBERON:0003053 | 64.26 | gold quality |
| lung | UBERON:0002048 | 64.22 | gold quality |
| liver | UBERON:0002107 | 64.08 | gold quality |
| urinary bladder | UBERON:0001255 | 63.88 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.88 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 62.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 62.67 | gold quality |
| islet of Langerhans | UBERON:0000006 | 62.19 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 61.29 | gold quality |
| muscle of leg | UBERON:0001383 | 60.57 | gold quality |
| endometrium | UBERON:0001295 | 60.46 | gold quality |
| pancreas | UBERON:0001264 | 59.62 | gold quality |
| gastrocnemius | UBERON:0001388 | 59.35 | gold quality |
| testis | UBERON:0000473 | 59.01 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- The present findings confirm that genetic abnormalities of the 15q11-q13 region are an important cause of Autistic spectrum disorder, accounting for approximately 1% of cases (PMID:19278672)
- in vitro restoration of PAR5 expression inhibited human glioma cell proliferation, invasion and migration by binding to EZH2 and regulating oncogene expression. This finding may provide a therapeutic approach for the future treatment of glioma (PMID:29048683)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.